Surwo (BI 456906) is a breakthrough compound that is already gaining recognition as an innovative therapy to support metabolism, appetite regulation and blood sugar levels. With dual active actions on glucagon and GLP-1 receptors, Surwo provides a wide range of health benefits that not only support weight loss, but also improve overall well-being.

Mazdu 5 MG is an innovative, multi-agonist peptide that is gaining recognition as an effective therapy for treating obesity and controlling blood glucose levels. Its powerful action on multiple receptors in the body puts it at the forefront of cutting-edge medical solutions such as thiothiazepatide and semaglutide. Studies show that Mazdu, combined with a proper diet and regular exercise, can significantly accelerate weight reduction while promoting metabolic regulation and hypertension control.